CX842A2303: A randomized, phase 3 multicenter clinical trial to confirm the clinical efficacy and evaluate the safety of linaprazan glurate compared to lansoprazole in participants with healed erosive esophagitis (EE) due to gastroesophageal reflux disease (GERD)